Learn about the basics of cancer immunotherapy, a highly promising new approach to cancer treatment. Medical experts along with patients who have been treated with immunotherapy will discuss how research and patient participation in clinical trials is helping us get closer to cures for all types of cancer. Space is limited, so register today!

People of all ages and cancer types are invited to attend this FREE half-day Saturday event. Caregivers, friends, family, and advocates are also encouraged to join.

Agenda

9:00am | Registration and networking

10:00am | Welcome by the Cancer Research Institute

10:15am | Learn the Basics of Immunotherapy – Aaron Miller, M.D., Ph.D. (UCSD)

10:45am | Expert panel: Immunotherapy research updates, moderated by Aaron Miller, M.D., Ph.D. (UCSD)with Tanya Dorff, M.D. (City of Hope); Roger Lo M.D., Ph.D. (UCLA); Rebecca Shatsky, M.D. (UCSD)

11:30am | Patient perspective: Hear from cancer survivor, Janie Ferling, who recieved immunotherapy treatment for melanoma

12:00pm | Lunch and networking

1:00pm | Learn about clinical trials

1:15pm | Patient panel: Hear directly from patients who have participated in immunotherapy clinical trials

2:15pm | Breakout sessions: Your choice of moderated, deeper dive discussions and Q&A with our experts in immunotherapy for:

  • breast cancer, moderated by Rebecca Shatsky, M.D. (UCSD)
  • melanoma, moderated by Roger Lo, M.D. Ph.D. (UCLA)
  • prostate cancer, moderated by Tanya Dorff, M.D. (City of Hope)
  • general immunotherapy, moderated by Aaron Miller, M.D., Ph.D. (UCSD)

3:30pm | Program close


Appointments with clinical trial navigators will be available throughout the day to help you find immunotherapy clinical trials, connect with study sites, and answer questions. The service is free and completely confidential. Indicate your interest for an appointment on the registration page.

Follow the Summit on social media with #CRISummit, or follow the Cancer Research Institute on FacebookTwitterInstagram, or YouTube

Please email your questions to the Cancer Research Institute at patients@cancerresearch.org